Mechanisms underlying progression in multiple sclerosis.

Area of Science:

• Neuroimmunology
• Neuropathology
• Multiple Sclerosis Pathogenesis

Background:

• Approved disease-modifying treatments for multiple sclerosis primarily target peripheral immunity, effectively reducing relapses but failing to halt disease progression and disability.
• Progressive multiple sclerosis is characterized by neuro-axonal loss within a chronic central nervous system (CNS) inflammatory milieu.
• The interplay between damage, repair, and brain reserve is crucial in managing disease progression.

Purpose of the Study:

• To provide an updated overview of the neuropathology of progressive multiple sclerosis.
• To summarize the key mechanisms driving disease progression in multiple sclerosis.
• To explore emerging therapeutic strategies informed by recent neuropathological insights.

Main Methods:

• Review of current literature on multiple sclerosis neuropathology and disease progression.
• Analysis of the roles of adaptive and innate immunity in CNS inflammation.
• Synthesis of findings on glial cell responses in progressive multiple sclerosis.

Main Results:

• Compartmentalized inflammation involving T-cells and B-cells in the leptomeninges and parenchyma is a critical driver of clinical progression.
• The glial response to chronic inflammatory injury is increasingly recognized as a key determinant of pathological and clinical outcomes.
• Understanding of disease progression has advanced, revealing mechanisms beyond peripheral immune modulation.

Conclusions:

• New therapeutic avenues for progressive multiple sclerosis are emerging that move beyond traditional T-cell and B-cell targeted therapies.
• Targeting glial responses and CNS-intrinsic mechanisms represents a promising direction for future treatments.
• A deeper understanding of neuropathology is essential for developing effective interventions against multiple sclerosis progression.